Prolonged response to TPO-R agonists

How do TPO-R agonists impact the daily lives of chronic ITP patients? Lessons from long-term studies

Global prostate cancer disparities and the parts both genetic and behavioural factors play

New players and targets in tumour vasculature

ecancermedicalscience editor's choice for July and August 2014

Treatment options in adult chronic idiopathic thrombocytopenic purpura: Panel discussion

Biochips separate cancer cells from blood cells

Mechanobiology and cancer microbiology

Integration of engineering and biology

Mechanobiological approach and understanding the 3D architecture of cancer

Cytoskeletal structures and the mechanics of cell matrix adhesion

Melanoma live: Making patient-focused therapy decisions